3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
38
Neoplasms
33
Depression
28
Fatigue
24
Prostatic Neoplasms
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Follicular
17
Multiple Myeloma
15
Lymphoma, Non-Hodgkin
14
Lymphoma, Mantle-Cell
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Burkitt Lymphoma
14
Lymphoma, B-Cell, Marginal Zone
13
Leukemia, Myeloid, Acute
13
Hodgkin Disease
13
Colorectal Neoplasms
13
Lymphoma, Large-Cell, Immunoblastic
12
Lung Neoplasms
12
Anxiety Disorders
12
Lymphoma
11
Leukemia, Myeloid, Chronic-Phase
11
Blast Crisis
11
Leukemia, Myeloid, Accelerated Phase
10
Recurrence
9
Pain
9
Lymphoma, T-Cell, Cutaneous
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Leukemia, Hairy Cell
9
Leukemia
9
Interventions
Propranolol
9
Timolol
5
Prednisolone
5
Adrenergic beta-Antagonists
3
Steroids
2
Solutions
2
Saline Solution
2
Prednisone
2
Methylprednisolone
2
Adrenal Cortex Hormones
2
prednisolone phosphate
1
Vincristine
1
Urine Specimen Collection
1
Tomography, Optical Coherence
1
Therapeutics
1
Sodium Chloride
1
Sirolimus
1
Population Groups
1
Ointments
1
Observation
1
Nadolol
1
Mupirocin
1
Lasers, Semiconductor
1
Lasers, Dye
1
Imiquimod
1
High-Energy Shock Waves
1
Hepatectomy
1
Gels
1
Everolimus
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hemangioma
×
Therapeutics
×
Clear all
NCT00866827
2019-01-11
Airway Vascular Lesions
University of Arkansas
Completed
75 enrolled